NEWS

  • September 12, 2019

    CroíValve Secures €4M in Additional Funding to Initiate Clinical Trials

    September 12, 2019 07:00 AM Eastern Daylight Time DUBLIN (BUSINESS WIRE)– €4 million in additional financing has been secured by CroíValve, a high potential start-up (HPSU) supported by Enterp...

    Read More
  • August 14, 2019

    Renovacor Closes $11 Million Series A Financing to Advance First Gene Therapy for a Rare Cardiovascular Disease

    August 14, 2019 07:00 AM Eastern Daylight Time PHILADELPHIA--(BUSINESS WIRE)--Renovacor, Inc, a preclinical-stage biopharmaceutical company focused on developing transformative gene therapy-...

    Read More
  • February 11, 2019

    FineHeart makes Fierce Medtech’s 2018 List

    February 11, 2019. FineHeart makes Fierce Medtech’s 2018 list of 15 exciting/innovative companies to watch. FierceMedTech’s Fierce 15 class of 2018 is aimed at advancement—whether it’s simpl...

    Read More
  • February 6, 2019

    Broadview Ventures 2018 Annual Report

    Broadview Ventures 2018 Annual Report...

    Read More
  • February 4, 2019

    Vectorious Medical Technologies Announces World’s First In-Heart Microcomputer for Left Atrial Pressure Monitoring

    Tel-Aviv, Israel (4 February, 2019) – Vectorious Medical Technologies, a medical device company enabling optimal management for heart failure patients, today announced the initiation of the VECTOR-H...

    Read More
  • December 4, 2018

    Remedy Publication: Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial

    Link to publication...

    Read More
  • November 9, 2018

    ZZ Biotech Publication: Final Results of the RHAPSODY Trial

    Link to publication...

    Read More
  • November 5, 2018

    Acesion Pharma Announces Positive Results for Novel Drug Targeting Atrial Fibrillation

    COPENHAGEN, Denmark — 5 November 2018: Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most common cardiac arrhy...

    Read More
  • September 18, 2018

    AtaCor Medical Raises $8.8M to Develop Substernal Cardiac Pacing System

    SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. (www.atacor.com) announced today that it has completed a $8.8M Series A financing. Co-led by Boston-based Broadview Ventures and Israel-base...

    Read More
  • July 10, 2018

    Aeromics Initiates Phase 1 Clinical Trial of CNS Edema Inhibitor AER-271 In Healthy Human Volunteers

    BRANFORD, Conn., July 9, 2018 /PRNewswire/ -- Aeromics, Inc. ("Aeromics" or "the Company"), a privately-held, clinical-stage pharmaceutical company focused on controlling cerebral edema for people af...

    Read More